
European Journal of Medicinal Chemistry p. 153 - 162 (1994)
Update date:2022-08-11
Topics:
Manfredini, S.
Guarneri, M.
Simoni, D.
Grana, E.
Boselli, C.
et al.
A series of 5-substituted-2-(dimethylaminomethyl)-furyl derivatives 4 was prepared, with the aim of discovering novel antimuscarinic agents which are selective for smooth muscle as opposed to cardiac tissue.Both non-quaternary and quaternary ammonium compounds were synthesised.The agonist starting point, furtrethonium 3, was gradually transformed into antagonist by introduction of lipophilic and bulky groups in position 5 of this molecule.In particular, the introduction of α-hydroxy-α-cyclohexylbenzyl moiety (compound 9b), a lipophilic group characteristic ofantimuscarinic agents, caused an appreciable increase of the antagonist's potency, and the lengthening of the distance between this lipophilic group and the furan ring, obtained by introduction of an ester, ether or amide group, led to some selectivity towards smooth muscle (compounds 19, 21, 25).Interestingly, compound 19, with an ester moiety as a spacer group, proved to be at least 20 times more potent in rat ileum (pKB = 7.3) and rat bladder (pKB = 7.2) than guinea-pig atria (pKB = 5.9). furtrethonium derivatives / cholinergic agents / antimuscarinic activity
View More
PINGYUAN SIHUAN PHARMACEUTICAL CO., LTD
Contact:+86-531-55696072
Address:#2766,yinxiu Road, Economic Development Zone, Pingyuan Country, Shandong Province, China.
TIANJIN NORTH JINHENG CHEMICAL PLANT.
Contact:0086-22-59952083
Address:DongShigu Country In JiXian TianJin China
website:http://www.lidepharma.com
Contact:+86-25-58409506
Address:N0.2-309 2/F Chungking Express Nos.36 Nathan Road,Kowloon, HK
shanghai jinshan pharmaceutical Co.,Ltd
Contact:021-57363011,13681638167
Address:No. 7966 Tingfeng Road,Jinshan,Shanghai,China
ChangZhou Mascotchem. Co.,Ltd.
website:http://www.mascotchem.com
Contact:86-519-85010339
Address:B-802,XingBei Building,391#,Tongjiang Middle Road New District,Changzhou,JS,China
Doi:10.1007/BF00759726
()Doi:10.1248/cpb.c19-00975
(2020)Doi:10.1016/0040-4020(58)88034-5
(1958)Doi:10.1002/adsc.200505312
(2006)Doi:10.1039/c8ta01609g
(2018)Doi:10.1016/j.molstruc.2014.01.031
(2014)